Inside information announcement arbitration award
Filed with HKEX · Stock code 1011 · · 2 pages · English
(Incorporated in the Cayman Islands with limited liability) (Stock Code: 1011) INSIDE INFORMATION ANNOUNCEMENT ARBITRATION AWARD This announcement is made by China NT Pharma Group Company Limited (the “Company”, together with its subsidiaries, the “Group”) pursuant to Rule 13.09(2) of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited and the Inside Informatio
China NT Pharma Group Co., Ltd. on 6ix
Earlier from China NT Pharma
- Appointment of auditor
- Connected transaction in relation to loan capitalisation involving subscription of shares under Specific mandate
- Supplemental announcement retirement of auditor
- China NT Pharma Group: Proposed granting of general mandates to issue shares and repurchase shares, proposed re-election of retiring directors and notice of annual general meeting
- Profit warning supplemental announcement
Later from China NT Pharma
- Voluntary announcement in relation to the application for compulsory enforcement by a wholly-owned subsidiary in respect of the shareholders' right to information of beijing kangchen biological technology co., limited
- 2026 Interim Report
- Notification Letter and Reply Form to Registered Shareholder
- Notification Letter and Request Form to Non-Registered Holder
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
Follow China NT Pharma into a list and get an email when it puts out news.
Follow China NT Pharma